Results 51 to 60 of about 44,049 (242)

Changing Trends of Vulvovaginal Candidiasis

open access: yesJournal of Laboratory Physicians, 2014
ABSTRACT Introduction: Vulvovaginal candidiasis is one of the most common infections seen in women. Materials and Methods: A total of 300 symptomatic women were studied. High vaginal swabs collected from each patient were processed by Gram stain, culture on Sabourauds dextrose agar and CHROM agar plates. Isolates were identified and
Sunanda Kulkarni   +2 more
openaire   +3 more sources

Topical treatment for acute vulvovaginal candidiasis [PDF]

open access: yesРМЖ. Мать и дитя, 2019
Topical treatment for acute vulvovaginal candidiasis V.G. Volkov Tula State University, Tula, Russian Federation Vulvovaginal candidiasis is a yeast infection of vulvar and vaginal mucosa caused by Candida species.
Volkov V.G.
doaj  

The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis

open access: yesМедицинский совет, 2016
The article tells about the key problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Candida albicans causes 75--80% of candidiasis cases.
V. N. Serov   +3 more
doaj   +1 more source

Vulvovaginal candidiasis: etiology, pathogenesis, diagnosis, treatment

open access: yesМедицинский совет, 2019
The article represents the main problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). It is noted that C. albicans causes candidiasis in 75-80% of cases.
N. A. Buralkina, O. V. Shabalova
doaj   +1 more source

Preserving reproductive health before the first pregnancy

open access: yesРепродуктивная эндокринология, 2022
Research objective: to evaluate the effectiveness of drugs based on decamethoxine for the treatment of inflammatory diseases of genital organs in adolescent girls entering reproductive age. Materials and methods. The study included 96 patients aged 17–19
О.V. Kravchenko
doaj   +1 more source

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

open access: yesClinical Infectious Diseases, 2021
Background Current treatment of vulvovaginal candidiasis (VVC) is largely limited to azole therapy. Ibrexafungerp is a first-in-class triterpenoid antifungal with broad-spectrum anti-Candida fungicidal activity.
J. Schwebke   +15 more
semanticscholar   +1 more source

Vulvovaginal candidiasis in a Flemish patient population [PDF]

open access: yesClinical Microbiology and Infection, 2005
Increased resistance to fluconazole has been reported in oral, oesophageal and urinary Candida isolates, but this has not been observed commonly in genital tract isolates. The rate of isolation of Candida spp. and their susceptibility to amphotericin B, flucytosine and azoles were determined in a number of clinical practices in the city of Ghent ...
Marc Dhont   +10 more
openaire   +3 more sources

Exposure to Systemic Antimicrobials During Pregnancy and Risk of Miscarriage: A Population‐Based Registry Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To estimate miscarriage risk following gestational antimicrobial exposure while addressing biases that have affected previous studies. Design Population‐based cohort study. Setting Linkage of four nationwide registries: Medical Birth Registry of Norway (MBRN), Norwegian Prescribed Drug Registry (NorPD), Norwegian Patient Registry ...
Thomas Boissiere‐O'Neill   +3 more
wiley   +1 more source

Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis.

open access: yesFuture Microbiology, 2021
Recurrent vulvovaginal candidiasis (RVVC) has significant disease, financial and quality-of-life burdens, affects women from all strata of society worldwide, and lacks an approved therapeutic solution.
J. Sobel, P. Nyirjesy
semanticscholar   +1 more source

Expression of mannanase and glucanases in lettuce chloroplasts and functional evaluation of enzyme cocktail against Candida albicans in oral cancer patient samples

open access: yesPlant Biotechnology Journal, Volume 23, Issue 7, Page 2689-2703, July 2025.
Transplastomic expression of mannanase in lettuce and tobacco chloroplasts and inhibition of Candida albicans from oral cancer patient samples by plant enzyme cocktail. Summary Candida albicans is a human pathogen responsible for several diseases. C. albicans cell wall contains chitin, glucan and mannan.
Iqra Fatima   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy